Alpha Fusion Initiates Company-Sponsored Clinical Trial of Alpha-Emitting Radiopharmaceutical af-001 in Patients with Differentiated Thyroid Cancer

Alpha Fusion Initiates Company-Sponsored Clinical Trial of Alpha-Emitting Radiopharmaceutical af-001 in Patients with Differentiated Thyroid Cancer

– Aiming to establish af-001 as a new therapeutic option for radioactive…

Kexing Biopharm Showcases Global Strategy and Partnership Opportunities at CPHI Frankfurt 2025

FRANKFURT, Germany, Oct. 31, 2025 /PRNewswire/ — From October 28th to 30th,…

Cboe Global Markets Reports Results for Third Quarter 2025 and Announces Strategic Realignment of Business Portfolio

Third Quarter Highlights* Record Diluted EPS for the Quarter of $2.85, Up…
Fox ESS Partners with Solar Juice to Enhance Energy Storage Solutions in Australia

Fox ESS Partners with Solar Juice to Enhance Energy Storage Solutions in Australia

MELBOURNE, Australia, Oct. 31, 2025 /PRNewswire/ — Fox ESS, a leading provider of…

Darkivore CTI & DRP Solution for Critical Sectors – Achieves Australian Data Sovereignty Compliance

SYDNEY, Oct. 31, 2025 /PRNewswire/ —  Potech’s Darkivore is now fully compliant…

Lufax Announces New Senior Management Hire

SHANGHAI, Oct. 31, 2025 /PRNewswire/ — Lufax Holding Ltd (NYSE: LU and…
ATTACK SHARK Unveils R11 ULTRA: A Carbon Fiber Flagship Redefining Lightweight Precision in Gaming

ATTACK SHARK Unveils R11 ULTRA: A Carbon Fiber Flagship Redefining Lightweight Precision in Gaming

NEW YORK, Oct. 31, 2025 /PRNewswire/ — Gaming is no longer just…

Lake Superior Acquisition Corp. Announces the Separate Trading of its Class A Ordinary Shares and Rights, Commencing on November 6, 2025

NEW YORK, Oct. 31, 2025 /PRNewswire/ — Lake Superior Acquisition Corp. (the "Company")…